Project Details
| Short title | Protocol 4003.1 |
|---|---|
| Acronym | Harbour Biomed 4003.1 |
| Status | Finished |
| Effective start/end date | 30/09/19 → 30/09/24 |
A Phase 1 Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of HBM4003 in Subjects with Advanced Solid Tumors
- Gurney, Howard (Primary Chief Investigator)
- Chapman, Nicola (Clinical Trial Unit Staff)
- Butala, Radhika (Clinical Trial Unit Staff)
- Parshionikar, Abhijit (Clinical Trial Unit Staff)
- Rajasekharan Nair, Archana (Clinical Trial Unit Staff)
Project: Other